| 1 |
35075935 | Investigation into the effect of the aspect ratio of cylindrical surface microstructure on von Willebrand factor damage. | 2022 Mar |
1 |
| 2 |
33387210 | Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox? | 2021 Jul |
1 |
| 3 |
33663351 | Differential diagnostic and treatment difficulties in a patient with acquired von Willebrand syndrome. | 2021 Dec |
1 |
| 4 |
34089550 | Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assay. | 2021 Sep |
3 |
| 5 |
34269464 | Coagulation function of never frozen liquid plasma stored for 40 days. | 2021 Jul |
2 |
| 6 |
34269797 | Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease. | 2021 Jul 27 |
1 |
| 7 |
34497208 | [The diagnosis and management of von Willebrand disease]. | 2021 |
1 |
| 8 |
34741678 | High levels of Von Willebrand factor markers in COVID-19: a systematic review and meta-analysis. | 2021 Nov 6 |
1 |
| 9 |
32607039 | Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study). | 2020 |
2 |
| 10 |
32774267 | A Case of Acquired von Willebrand Disease Secondary to Myeloproliferative Neoplasm. | 2020 May-Aug |
3 |
| 11 |
30450617 | Spray-dried plasma deficient in high-molecular-weight multimers of von Willebrand factor retains hemostatic properties. | 2019 Feb |
2 |
| 12 |
30592326 | Automated assays for von Willebrand factor activity. | 2019 Apr |
4 |
| 13 |
30849118 | Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue. | 2019 Mar |
2 |
| 14 |
31229334 | Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor. | 2019 Nov |
4 |
| 15 |
31359769 | Bleeding Symptoms and von Willebrand Factor Levels: 30-Year Experience in a Tertiary Care Center. | 2019 Jan-Dec |
1 |
| 16 |
28957942 | Purification and characterization of a new highly pure, double virus inactivated von Willebrand factor concentrate. | 2018 Jan |
2 |
| 17 |
29140542 | Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resection. | 2018 Apr |
1 |
| 18 |
29168270 | A comparative evaluation of a new fully automated assay for von Willebrand factor collagen binding activity to an established method. | 2018 Jan |
1 |
| 19 |
29355554 | Dual inhibition of HY023016 based on binding properties of platelet membrane receptor subunit glycoprotein Ibα and thrombin exosites. | 2018 Mar 5 |
2 |
| 20 |
29651351 | Acquired von Willebrand Disease Associated with Mantle Cell Lymphoma. | 2018 |
1 |
| 21 |
29897666 | An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS-VWF study. | 2018 Jun 13 |
1 |
| 22 |
29985231 | Perhaps it's not the platelet: Ristocetin uncovers the potential role of von Willebrand factor in impaired platelet aggregation following traumatic brain injury. | 2018 Nov |
6 |
| 23 |
30046704 | Current issues in diagnosis and treatment of von Willebrand disease. | 2018 Jan |
1 |
| 24 |
30084138 | The elusive and heterogeneous pattern of type 2M von Willebrand disease: A diagnostic challenge. | 2018 Aug 6 |
1 |
| 25 |
30337247 | vWA proteins of Leptospira interrogans induce hemorrhage in leptospirosis by competitive inhibition of vWF/GPIb-mediated platelet aggregation. | 2018 Nov |
1 |
| 26 |
27978591 | Phenotypic Parameters in Genotypically Selected Type 2B von Willebrand Disease Patients: A Large, Single-Center Experience Including a New Novel Mutation. | 2017 Feb |
2 |
| 27 |
28120508 | Validation of automated latex von Willebrand factor activity assay in a new prospective study including post-treatment patient samples. | 2017 Jun |
2 |
| 28 |
28142075 | Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin, but not by atorvastatin. | 2017 Feb |
1 |
| 29 |
28279966 | Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1-A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro. | 2017 May |
1 |
| 30 |
28603902 | Extracellular signal-regulated kinase 5 associates with casein kinase II to regulate GPIb-IX-mediated platelet activation via the PTEN/PI3K/Akt pathway. | 2017 Aug |
1 |
| 31 |
28640903 | Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue. | 2017 |
1 |
| 32 |
28804843 | Diagnosis or Exclusion of von Willebrand Disease Using Laboratory Testing. | 2017 |
3 |
| 33 |
28804846 | Laboratory Testing for von Willebrand Factor Ristocetin Cofactor (VWF:RCo). | 2017 |
4 |
| 34 |
28804847 | Laboratory Testing for von Willebrand Factor Activity by Glycoprotein Ib Binding Assays (VWF:GPIb). | 2017 |
6 |
| 35 |
28804849 | Ristocetin-Induced Platelet Aggregation (RIPA) and RIPA Mixing Studies. | 2017 |
4 |
| 36 |
29126301 | Coagulation Testing in the Core Laboratory. | 2017 Nov 8 |
2 |
| 37 |
27040683 | Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias. | 2016 May |
1 |
| 38 |
27052467 | The functions of the A1A2A3 domains in von Willebrand factor include multimerin 1 binding. | 2016 Jul 4 |
1 |
| 39 |
27148840 | Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality. | 2016 Jul |
2 |
| 40 |
27184018 | Evaluation of the role of the GPIb-IX-V receptor complex in development of the platelet storage lesion. | 2016 Oct |
2 |
| 41 |
27237807 | Biological diagnosis of von Willebrand disease: analytical characteristics of Innovance vWF:Ac assay kit on STA-R Evolution Expert series analyzer (Stago). | 2016 Jun 1 |
1 |
| 42 |
27554083 | N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance. | 2016 Oct 13 |
1 |
| 43 |
27651919 | Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation. | 2016 |
2 |
| 44 |
27716777 | Thioredoxin Inhibitors Attenuate Platelet Function and Thrombus Formation. | 2016 |
1 |
| 45 |
27749315 | Von Willebrand disease in sub-Saharan Africa: a first severe case reported in Cameroon. | 2016 Oct |
1 |
| 46 |
27913545 | What have we learned from large population studies of von Willebrand disease? | 2016 Dec 2 |
2 |
| 47 |
25661290 | Comparison of automated von Willebrand factor activity assays. | 2015 Apr |
2 |
| 48 |
25728415 | Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance. | 2015 May |
1 |
| 49 |
25753785 | Platelet function analyser (PFA-100) results and von Willebrand factor deficiency: a 16-year 'real-world' experience. | 2015 Sep |
2 |
| 50 |
25935884 | Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor. | 2015 Jun |
5 |